174 related articles for article (PubMed ID: 37193683)
1. Relationship between BCL2 mutations and follicular lymphoma outcome in the chemoimmunotherapy era.
Correia C; Maurer MJ; McDonough SJ; Schneider PA; Ross PE; Novak AJ; Feldman AL; Cerhan JR; Slager SL; Witzig TE; Eckloff BW; Li H; Nowakowski GS; Kaufmann SH
Blood Cancer J; 2023 May; 13(1):81. PubMed ID: 37193683
[TBL] [Abstract][Full Text] [Related]
2. BCL2 mutations do not confer adverse prognosis in follicular lymphoma patients treated with rituximab.
Huet S; Szafer-Glusman E; Tesson B; Xerri L; Fairbrother WJ; Mukhyala K; Bolen C; Punnoose E; Tonon L; Chassagne-Clément C; Feugier P; Viari A; Jardin F; Salles G; Sujobert P
Am J Hematol; 2017 Jun; 92(6):515-519. PubMed ID: 28247997
[TBL] [Abstract][Full Text] [Related]
3. BCL2 mutations are associated with increased risk of transformation and shortened survival in follicular lymphoma.
Correia C; Schneider PA; Dai H; Dogan A; Maurer MJ; Church AK; Novak AJ; Feldman AL; Wu X; Ding H; Meng XW; Cerhan JR; Slager SL; Macon WR; Habermann TM; Karp JE; Gore SD; Kay NE; Jelinek DF; Witzig TE; Nowakowski GS; Kaufmann SH
Blood; 2015 Jan; 125(4):658-67. PubMed ID: 25452615
[TBL] [Abstract][Full Text] [Related]
4. [The role of translocations involving c-MYC/8q24, BCL2/18q21 and/or BCL6/3q27 genes in patients with follicular lymphoma. Retrospective analysis of single - centre data].
Misyurina AE; Kravchenko SK; Kovrigina AM; Magomedova AU; Plastinina LV; Obukhova TN; Misyurin AV; Misyurin VA; Grebenuk LA; Babaeva FE; Baryakh EA; Vorobiev AI
Ter Arkh; 2019 Jul; 91(7):52-62. PubMed ID: 32598736
[TBL] [Abstract][Full Text] [Related]
5. BCL2 mutation spectrum in B-cell non-Hodgkin lymphomas and patterns associated with evolution of follicular lymphoma.
Burkhard R; Bhagat G; Cogliatti SB; Rossi D; Gaidano G; Pasqualucci L; Novak U
Hematol Oncol; 2015 Mar; 33(1):23-30. PubMed ID: 24496723
[TBL] [Abstract][Full Text] [Related]
6. Integration of gene mutations in risk prognostication for patients receiving first-line immunochemotherapy for follicular lymphoma: a retrospective analysis of a prospective clinical trial and validation in a population-based registry.
Pastore A; Jurinovic V; Kridel R; Hoster E; Staiger AM; Szczepanowski M; Pott C; Kopp N; Murakami M; Horn H; Leich E; Moccia AA; Mottok A; Sunkavalli A; Van Hummelen P; Ducar M; Ennishi D; Shulha HP; Hother C; Connors JM; Sehn LH; Dreyling M; Neuberg D; Möller P; Feller AC; Hansmann ML; Stein H; Rosenwald A; Ott G; Klapper W; Unterhalt M; Hiddemann W; Gascoyne RD; Weinstock DM; Weigert O
Lancet Oncol; 2015 Sep; 16(9):1111-1122. PubMed ID: 26256760
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathological and genomic analysis of double-hit follicular lymphoma: comparison with high-grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements.
Miyaoka M; Kikuti YY; Carreras J; Ikoma H; Hiraiwa S; Ichiki A; Kojima M; Ando K; Yokose T; Sakai R; Hoshikawa M; Tomita N; Miura I; Takata K; Yoshino T; Takizawa J; Bea S; Campo E; Nakamura N
Mod Pathol; 2018 Feb; 31(2):313-326. PubMed ID: 28984304
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathological analysis of follicular lymphoma with BCL2, BCL6, and MYC rearrangements.
Ikoma H; Miyaoka M; Hiraiwa S; Yukie Kikuti Y; Shiraiwa S; Hara R; Kojima M; Ohmachi K; Ando K; Carreras J; Nakamura N
Pathol Int; 2022 Jun; 72(6):321-331. PubMed ID: 35297566
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathological and prognostic significance of
Kim M; Hwang HS; Son EM; Cho H; Yoon DH; Suh C; Park CS; Go H; Huh J
Leuk Lymphoma; 2020 Dec; 61(14):3342-3350. PubMed ID: 32921221
[No Abstract] [Full Text] [Related]
10. Prognostic implications of histologic grade and intensity of Bcl-2 expression in follicular lymphomas undergoing rituximab-containing therapy.
Maeshima AM; Taniguchi H; Nomoto J; Miyamoto K; Fukuhara S; Munakata W; Maruyama D; Kim SW; Watanabe T; Kobayashi Y; Tobinai K; Tsuda H
Hum Pathol; 2013 Nov; 44(11):2529-35. PubMed ID: 23916290
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of B-cell differentiation genes encoding proteins in diffuse large B-cell lymphoma and follicular lymphoma grade 3.
Borovecki A; Korać P; Nola M; Ivanković D; Jaksić B; Dominis M
Croat Med J; 2008 Oct; 49(5):625-35. PubMed ID: 18925696
[TBL] [Abstract][Full Text] [Related]
12. Mutational landscape of high-grade B-cell lymphoma with
Künstner A; Witte HM; Riedl J; Bernard V; Stölting S; Merz H; Olschewski V; Peter W; Ketzer J; Busch Y; Trojok P; Bubnoff NV; Busch H; Feller AC; Gebauer N
Haematologica; 2022 Aug; 107(8):1850-1863. PubMed ID: 34788985
[TBL] [Abstract][Full Text] [Related]
13. Relative frequency and clinicopathologic characteristics of MYC-rearranged follicular lymphoma.
Chaudhary S; Brown N; Song JY; Yang L; Skrabek P; Nasr MR; Wong JT; Bedell V; Murata-Collins J; Kochan L; Li J; Zhang W; Chan WC; Weisenburger DD; Perry AM
Hum Pathol; 2021 Aug; 114():19-27. PubMed ID: 33964277
[TBL] [Abstract][Full Text] [Related]
14. Double-hit follicular lymphoma with MYC and BCL2 translocations: a study of 7 cases with a review of literature.
Miao Y; Hu S; Lu X; Li S; Wang W; Medeiros LJ; Lin P
Hum Pathol; 2016 Dec; 58():72-77. PubMed ID: 27544800
[TBL] [Abstract][Full Text] [Related]
15. Application of circulating tumour DNA in terms of prognosis prediction in Chinese follicular lymphoma patients.
Zhao M; Li Q; Yang J; Zhang M; Liu X; Zhang H; Huang Y; Li J; Bao J; Wang J; Du J; Guan T; Su L
Front Genet; 2023; 14():1066808. PubMed ID: 37152994
[No Abstract] [Full Text] [Related]
16. Clinical significance of 'double-hit' and 'double-expression' lymphomas.
Ma Z; Niu J; Cao Y; Pang X; Cui W; Zhang W; Li X
J Clin Pathol; 2020 Mar; 73(3):126-138. PubMed ID: 31615842
[TBL] [Abstract][Full Text] [Related]
17. Follicular lymphoma and diffuse large B-cell lymphoma with BCL2 and IRF4 rearrangements in adult patients.
Yuan J; Liu H; Hu S; Miranda RN; Xu X; Bayerl MG; Artymiuk CJ; Berg H; King RL; Shi M; He R; Viswanatha D; Medeiros LJ; McPhail ED
Hum Pathol; 2023 Nov; 141():22-29. PubMed ID: 37634651
[TBL] [Abstract][Full Text] [Related]
18. Concomitant 1p36 deletion and TNFRSF14 mutations in primary cutaneous follicle center lymphoma frequently expressing high levels of EZH2 protein.
Gángó A; Bátai B; Varga M; Kapczár D; Papp G; Marschalkó M; Kuroli E; Schneider T; Csomor J; Matolcsy A; Bödör C; Szepesi Á
Virchows Arch; 2018 Oct; 473(4):453-462. PubMed ID: 29858685
[TBL] [Abstract][Full Text] [Related]
19. Prognostic impact of history of follicular lymphoma, induction regimen and stem cell transplant in patients with MYC/BCL2 double hit lymphoma.
Li S; Saksena A; Desai P; Xu J; Zuo Z; Lin P; Tang G; Yin CC; Seegmiller A; Jorgensen JL; Miranda RN; Reddy NM; Bueso-Ramos C; Medeiros LJ
Oncotarget; 2016 Jun; 7(25):38122-38132. PubMed ID: 27203548
[TBL] [Abstract][Full Text] [Related]
20. High frequency of BCL2 gene rearrangement-negative follicular lymphoma in northwestern Italy.
Magnoli F; Marchiori D; Facchi S; Martin V; Campiotti L; Merli M; Sessa F; Tibiletti MG; Uccella S
Cancer Genet; 2023 Jun; 274-275():1-9. PubMed ID: 36917896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
